Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuropsychological Tests | 29 | 2022 | 517 | 3.110 |
Why?
|
| Malingering | 6 | 2022 | 36 | 1.670 |
Why?
|
| Cognition Disorders | 13 | 2021 | 342 | 1.620 |
Why?
|
| Brain Injuries | 6 | 2017 | 268 | 1.250 |
Why?
|
| Veterans | 9 | 2022 | 904 | 1.180 |
Why?
|
| Attention | 5 | 2013 | 225 | 0.810 |
Why?
|
| Psychometrics | 5 | 2018 | 514 | 0.670 |
Why?
|
| Reproducibility of Results | 7 | 2022 | 2077 | 0.570 |
Why?
|
| MMPI | 1 | 2014 | 40 | 0.490 |
Why?
|
| Psychomotor Performance | 2 | 2014 | 213 | 0.480 |
Why?
|
| Hospitals, Psychiatric | 1 | 2014 | 59 | 0.470 |
Why?
|
| Health Resources | 1 | 2014 | 76 | 0.460 |
Why?
|
| Middle Aged | 33 | 2021 | 21119 | 0.450 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 565 | 0.450 |
Why?
|
| Self-Assessment | 2 | 2006 | 69 | 0.440 |
Why?
|
| Quality of Health Care | 2 | 2014 | 322 | 0.420 |
Why?
|
| Adult | 35 | 2021 | 21379 | 0.420 |
Why?
|
| Patient Compliance | 1 | 2014 | 402 | 0.390 |
Why?
|
| Mental Disorders | 2 | 2014 | 659 | 0.390 |
Why?
|
| Emergency Service, Hospital | 2 | 2014 | 711 | 0.390 |
Why?
|
| Male | 40 | 2021 | 37283 | 0.380 |
Why?
|
| Mental Processes | 2 | 2008 | 22 | 0.360 |
Why?
|
| Aged | 18 | 2021 | 14842 | 0.350 |
Why?
|
| Memory | 4 | 2015 | 214 | 0.350 |
Why?
|
| Stress Disorders, Post-Traumatic | 4 | 2017 | 1506 | 0.340 |
Why?
|
| Humans | 45 | 2022 | 68549 | 0.320 |
Why?
|
| Cognition | 7 | 2021 | 512 | 0.320 |
Why?
|
| Cholinesterase Inhibitors | 3 | 2021 | 58 | 0.310 |
Why?
|
| Cognitive Dysfunction | 2 | 2021 | 176 | 0.310 |
Why?
|
| Substance-Related Disorders | 4 | 2017 | 1242 | 0.310 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2021 | 105 | 0.300 |
Why?
|
| Mental Recall | 3 | 2002 | 72 | 0.300 |
Why?
|
| Female | 31 | 2021 | 38021 | 0.290 |
Why?
|
| Mood Disorders | 1 | 2008 | 132 | 0.280 |
Why?
|
| Anxiety | 2 | 2008 | 422 | 0.280 |
Why?
|
| Sickness Impact Profile | 1 | 2006 | 27 | 0.280 |
Why?
|
| Intelligence Tests | 1 | 2005 | 32 | 0.270 |
Why?
|
| Outpatients | 3 | 2017 | 127 | 0.260 |
Why?
|
| Indans | 4 | 2007 | 20 | 0.240 |
Why?
|
| Schizophrenia | 4 | 2007 | 206 | 0.240 |
Why?
|
| Piperidines | 4 | 2007 | 123 | 0.230 |
Why?
|
| Factor Analysis, Statistical | 2 | 2018 | 201 | 0.230 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2005 | 189 | 0.220 |
Why?
|
| Psychiatric Status Rating Scales | 6 | 2017 | 782 | 0.210 |
Why?
|
| Schizophrenic Psychology | 3 | 2007 | 53 | 0.210 |
Why?
|
| Cocaine-Related Disorders | 3 | 2009 | 504 | 0.200 |
Why?
|
| Verbal Learning | 3 | 2005 | 29 | 0.200 |
Why?
|
| Hospitals, Veterans | 3 | 2017 | 147 | 0.190 |
Why?
|
| Rivastigmine | 1 | 2021 | 6 | 0.190 |
Why?
|
| Depression | 4 | 2017 | 942 | 0.180 |
Why?
|
| Self Report | 1 | 2022 | 370 | 0.180 |
Why?
|
| Geriatric Assessment | 2 | 2011 | 107 | 0.180 |
Why?
|
| Psychotic Disorders | 3 | 2007 | 157 | 0.170 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 805 | 0.160 |
Why?
|
| Hospitalization | 3 | 2014 | 977 | 0.160 |
Why?
|
| Memory Disorders | 2 | 2015 | 111 | 0.150 |
Why?
|
| Sensitivity and Specificity | 5 | 2015 | 1753 | 0.150 |
Why?
|
| Nootropic Agents | 2 | 2007 | 18 | 0.140 |
Why?
|
| Space Perception | 1 | 1996 | 44 | 0.140 |
Why?
|
| Problem Solving | 1 | 1996 | 36 | 0.140 |
Why?
|
| Discrimination Learning | 1 | 1996 | 45 | 0.140 |
Why?
|
| Dominance, Cerebral | 1 | 1996 | 65 | 0.130 |
Why?
|
| United States | 4 | 2017 | 7338 | 0.130 |
Why?
|
| Implosive Therapy | 1 | 2017 | 171 | 0.130 |
Why?
|
| Functional Laterality | 1 | 1996 | 240 | 0.130 |
Why?
|
| Models, Statistical | 1 | 2018 | 448 | 0.130 |
Why?
|
| Disability Evaluation | 1 | 2017 | 298 | 0.130 |
Why?
|
| Affect | 2 | 2006 | 218 | 0.120 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1996 | 138 | 0.120 |
Why?
|
| Retina | 1 | 1996 | 252 | 0.120 |
Why?
|
| Cerebral Cortex | 3 | 2005 | 415 | 0.120 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2013 | 307 | 0.120 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 193 | 0.110 |
Why?
|
| Frontal Lobe | 3 | 2007 | 156 | 0.110 |
Why?
|
| Double-Blind Method | 7 | 2021 | 1738 | 0.110 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2014 | 257 | 0.110 |
Why?
|
| Logistic Models | 2 | 2008 | 1419 | 0.110 |
Why?
|
| Antipsychotic Agents | 2 | 2007 | 247 | 0.110 |
Why?
|
| Adolescent | 5 | 2008 | 8904 | 0.100 |
Why?
|
| Semantics | 1 | 1990 | 37 | 0.090 |
Why?
|
| Brain Mapping | 4 | 2005 | 531 | 0.090 |
Why?
|
| Alcoholism | 1 | 1999 | 1109 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2007 | 2222 | 0.090 |
Why?
|
| Amlodipine | 1 | 2009 | 31 | 0.080 |
Why?
|
| Interviews as Topic | 2 | 2009 | 392 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 546 | 0.080 |
Why?
|
| Epilepsy | 2 | 2009 | 336 | 0.080 |
Why?
|
| Calcium Channel Blockers | 1 | 2009 | 137 | 0.080 |
Why?
|
| Valproic Acid | 1 | 2009 | 93 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2021 | 7268 | 0.080 |
Why?
|
| Reference Values | 2 | 2006 | 579 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2015 | 4843 | 0.080 |
Why?
|
| Antidepressive Agents | 1 | 2009 | 216 | 0.080 |
Why?
|
| Population Surveillance | 2 | 2009 | 285 | 0.080 |
Why?
|
| Regression Analysis | 2 | 2007 | 737 | 0.070 |
Why?
|
| Intelligence | 1 | 2006 | 45 | 0.070 |
Why?
|
| Social Support | 1 | 2008 | 423 | 0.060 |
Why?
|
| Memory, Short-Term | 1 | 2005 | 79 | 0.060 |
Why?
|
| Sleep Deprivation | 1 | 2005 | 81 | 0.060 |
Why?
|
| Risk Factors | 3 | 2009 | 5720 | 0.060 |
Why?
|
| Telemedicine | 1 | 2012 | 699 | 0.060 |
Why?
|
| Task Performance and Analysis | 2 | 2002 | 150 | 0.060 |
Why?
|
| Sex Factors | 1 | 2008 | 1265 | 0.060 |
Why?
|
| Deception | 1 | 2004 | 18 | 0.060 |
Why?
|
| Cross-Over Studies | 4 | 2007 | 260 | 0.060 |
Why?
|
| Speech | 1 | 2005 | 118 | 0.060 |
Why?
|
| Age Factors | 1 | 2008 | 1860 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 1465 | 0.050 |
Why?
|
| Trail Making Test | 1 | 2002 | 7 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2005 | 1040 | 0.050 |
Why?
|
| Transdermal Patch | 1 | 2021 | 21 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2021 | 216 | 0.050 |
Why?
|
| Quality of Life | 2 | 2006 | 1515 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2009 | 1329 | 0.040 |
Why?
|
| Time Factors | 3 | 2009 | 4655 | 0.040 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 1999 | 151 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2011 | 219 | 0.040 |
Why?
|
| Motor Skills | 1 | 1999 | 88 | 0.040 |
Why?
|
| Brain | 3 | 2004 | 2176 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2017 | 7028 | 0.040 |
Why?
|
| Drug Therapy, Combination | 3 | 2007 | 648 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2009 | 791 | 0.040 |
Why?
|
| Pilot Projects | 3 | 2012 | 1341 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2001 | 1851 | 0.040 |
Why?
|
| Recurrence | 2 | 2009 | 948 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 1999 | 339 | 0.040 |
Why?
|
| Reaction Time | 1 | 1996 | 170 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1999 | 435 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 1996 | 125 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 2356 | 0.030 |
Why?
|
| Patient Readmission | 1 | 1996 | 267 | 0.030 |
Why?
|
| Benzodiazepines | 2 | 2007 | 130 | 0.030 |
Why?
|
| South Carolina | 2 | 2009 | 2752 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2009 | 3256 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 306 | 0.030 |
Why?
|
| Remote Consultation | 1 | 2012 | 50 | 0.030 |
Why?
|
| Rural Health Services | 1 | 2012 | 101 | 0.020 |
Why?
|
| Amnesia | 1 | 1990 | 17 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2011 | 107 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2012 | 652 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 1990 | 102 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2009 | 80 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2010 | 180 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1582 | 0.020 |
Why?
|
| Executive Function | 1 | 2009 | 106 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1046 | 0.020 |
Why?
|
| Atrophy | 1 | 2007 | 112 | 0.020 |
Why?
|
| Clozapine | 1 | 2007 | 46 | 0.020 |
Why?
|
| Risperidone | 1 | 2007 | 48 | 0.020 |
Why?
|
| Language | 1 | 2008 | 120 | 0.020 |
Why?
|
| Registries | 1 | 2009 | 730 | 0.020 |
Why?
|
| Rest | 1 | 2005 | 78 | 0.020 |
Why?
|
| Lie Detection | 1 | 2004 | 6 | 0.010 |
Why?
|
| Individuality | 1 | 2004 | 44 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 1549 | 0.010 |
Why?
|
| Gyrus Cinguli | 1 | 2004 | 113 | 0.010 |
Why?
|
| Placebos | 1 | 2003 | 195 | 0.010 |
Why?
|
| Oxygen | 1 | 2004 | 386 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2005 | 705 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 5710 | 0.010 |
Why?
|
| Combat Disorders | 1 | 2002 | 102 | 0.010 |
Why?
|
| Pirenzepine | 1 | 2001 | 17 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 2001 | 45 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2009 | 2798 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2002 | 201 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 689 | 0.010 |
Why?
|
| Pattern Recognition, Visual | 1 | 1999 | 69 | 0.010 |
Why?
|
| Hospital Units | 1 | 1996 | 21 | 0.010 |
Why?
|
| Observer Variation | 1 | 1996 | 330 | 0.010 |
Why?
|
| Internal Medicine | 1 | 1996 | 118 | 0.010 |
Why?
|
| Prefrontal Cortex | 1 | 2001 | 639 | 0.010 |
Why?
|
| Data Collection | 1 | 1996 | 420 | 0.010 |
Why?
|
| Clinical Competence | 1 | 1996 | 657 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1996 | 3703 | 0.010 |
Why?
|